RadioWire
From Collegiate Presswire

Last Updated: Sep 18th, 2003 - 15:42:22   

 Front Page   Entertainment   Computers   Careers   Fashion   Travel   Print   Radio 
Levitra Gets FDA Approval

Source: NBN/CP RadioWire
Aug 20, 2003, 16:34
Email this article
 Printer friendly page

Good news for the 30 million American men who experience a decline in their erectile function.1 The U.S. Food and Drug Administration has just approved Levitra, a new oral prescription medication for the treatment of erectile dysfunction. Urologist Doctor Marc Gittelman:

  

�Levitra is an important new option for improving erectile function in men with E-D.  In addition to achieving an erection, men are looking to enhance both the quality and reliability of their sexual response.  The FDA approval of Levitra provides patients and physicians with a new option that is effective and well-tolerated.�

 

Levitra is expected to be available in pharmacies nationwide within the next few weeks.  To learn more, talk with your doctor or visit w-w-w-dot-levitra-dot-com.  The most commonly reported side effects are headache, flushing and stuffy or runny nose.

 

REFERENCE:

1. National Institutes of Health, Consensus Development Conference Statement, December 7-9, 1992. Online data: . (accessed 8/26/02).

 

2. Package insert (proposed annotated dated 2/4/03).

 

 

CLICK HERE to download a transcript of this story:
https://www.cpwire.com/click.asp?feature=https://216.86.33.66/levitra.doc

CLICK HERE to download a multimedia (MP3) file of this story:
https://www.cpwire.com/click.asp?feature=https://216.86.33.66/levitra.mp3




Search




Advanced Search

Latest Headlines:
Radio


Ortho-McNeil Personal Pak

Red Cross Urges Hurricane Preparedness

Rafael Palmeiro on Wheaties Box

�Excellence Through Ethics� Curriculum

Antibiotics For Childhood Ear Infections

McDonald's Partners With Fitness Expert Bob Greene

Prilosec OTC Hits Wal-Mart Shelves

Steer Clear of Pot

Preparing for Hurricane Season

Light Cycle

More

  
    
Copyright © 2003 Collegiate Presswire Inc., All Rights Reserved.